Clinical Trial Update: TumorGlow Intraoperative Molecular Imaging (IMI) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for TumorGlow intraoperative molecular imaging (IMI) sponsored by the University of Pennsylvania; a solid tumor study currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• TumorGlow IMI

Snippet

Sponsor: University of Pennsylvania | Conditions: Tumor, Solid | Phase 1, Phase 2 | Status: RECRUITING